Nordea Investment Management Ab Verve Therapeutics, Inc. Transaction History
Nordea Investment Management Ab
- $103 Billion
- Q2 2025
A detailed history of Nordea Investment Management Ab transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 675,849 shares of VERV stock, worth $7.52 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
675,849Holding current value
$7.52 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VERV
# of Institutions
200Shares Held
83.1MCall Options Held
350KPut Options Held
186K-
Alphabet Inc. Mountain View, CA12.2MShares$135 Million8.86% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$76.8 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.19MShares$46.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.5 Million2.14% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...